AZNCF — Stock activity · TradeandTellAZNC
AZNCF
$187.10+$3.93 (+2.15%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$146.10 – $195.00
84% from low
Held by traders on TradeandTell
No one on the platform currently holds AZNCF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in AZNCF as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.58% ($4.82/share)
| Ex-date | Per share | Pay date |
|---|
| 2026-02-19 | $1.5950 | 2026-03-23 |
| 2025-08-08 | $0.7670 | 2025-09-08 |
| 2025-02-21 | $1.6800 | 2025-03-24 |
| 2024-08-09 | $0.7760 | 2024-09-09 |
| 2024-02-22 | $1.5600 | 2024-03-25 |
Recent trades on TradeandTell
No one on the platform has traded AZNCF yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $62.3B | +6.3% | $10.29 | $9.40–$10.93 | 18.2× | 1 |
| 2027 | $66.5B | +6.6% | $11.57 | $10.57–$12.29 | 16.2× | 1 |
| 2028 | $70.5B | +6.0% | $13.00 | $11.87–$13.81 | 14.4× | 1 |
| 2029 | $75.1B | +6.7% | $14.51 | $13.25–$15.41 | 12.9× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2025-11-06 | $2.29 | $2.38 | +3.9% |
| 2025-07-29 | $2.16 | $2.17 | +0.5% |
| 2025-04-29 | $2.25 | $2.49 | +10.7% |
| 2025-02-06 | $2.07 | $2.09 | +1.0% |
| 2024-11-12 | $2.04 | $2.08 | +2.0% |
| 2024-07-25 | $1.97 | $1.98 | +0.5% |
| 2024-04-25 | $1.91 | $2.06 | +7.9% |
| 2024-02-08 | $1.46 |
DCF fair valuemodel estimate
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| AZNCFAstraZeneca PLC | $189.90 | -1.35% | $294.4B | — |
| CHGCFChugai Pharmaceutical Co., Ltd. | $43.22 | -0.84% | $71.1B | — |
| CHGCYChugai Pharmaceutical Co., Ltd. | $21.61 | -3.61% | $71.1B | — |
| FSNUYFresenius SE & Co. KGaA | $13.70 | -0.95% | $123.5B | — |
| NONOFNovo Nordisk A/S | $44.95 |
| NVSEFNovartis AG | $157.90 | +0.00% | $300.1B | — |
| RHHBFRoche Holding AG | $443.68 | -2.68% | $353.5B | — |
Source: Financial Modeling Prep · peers by sector/industry